SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price
SOPHStock
$6.73+51.58%52W
Market Cap$572.91M
P/E—
PEG Ratio—
Div yield—
Beta1.08
SOPH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)25.78%
Price vs S&P 500 (4W)-17.00%
VGM Score58.39
SOPH Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.22 | -$0.20 | +10.95%(+$0.02) | |
| Q1 2026 | -$0.24 | -$0.19 | +20.42%(+$0.05) | |
| Q4 2025 | -$0.20 | -$0.17 | +14.64%(+$0.03) | |
| Q3 2025 | -$0.20 | -$0.20 | +1.65%(+$0.00) | |
| Q2 2025 | -$0.17 | -$0.25 | -44.53%(-$0.08) |
SOPH Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.30
4.30
4.27
4.27
Industry Peers — Computer Processing & Data(94)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
SOPHSOPHiA GENETICS SA Ordinary Shares | D | B | B | 6.6x | 23.6% | 66.6% | -85.5% | $6.73 |
| ADPAutomatic Data Processing | D | C | B | 5.2x | 6.7% | 46.5% | 26.3% | $288.90 |
| WDAYWorkday, Inc. Class A Common Stock | D | B | B | 4.7x | 13.3% | 75.8% | 10.7% | $190.81 |
| RDDTReddit, Inc. | F | A | C | 10.8x | 66.6% | 91.4% | 28.3% | $156.14 |
| VRSKVerisk Analytics, Inc. Common Stock | D | D | B | 7.9x | 5.0% | 70.2% | 43.4% | $190.90 |
| TOSTToast, Inc. | D | A | B | 2.7x | 23.0% | 26.7% | 6.3% | $31.62 |
| HNGEHinge Health, Inc. | F | B | A | 11.1x | 10.2% | 84.5% | 13.0% | $99.16 |
| RNGRINGCENTRAL, INC. | C | C | A | 2.4x | 5.2% | 71.8% | 6.7% | $75.44 |
| BILIBilibili Inc. American Depositary Shares | C | B | D | 1.3x | 6.9% | 37.0% | 4.5% | $14.07 |
| PEGAPegasystems Inc | D | C | C | 3.3x | 3.6% | 75.6% | 9.9% | $34.54 |
| APLDApplied Digital Corporation Common Stock | F | A | D | 6.4x | 457.0% | 20.2% | -35.6% | $18.05 |
About SOPHiA GENETICS SA Ordinary Shares
Sophia Genetics SA is a healthcare technology company that provides a cloud-based SaaS platform for analyzing complex diagnostic data and generating clinical insights. The platform enables data-driven medicine across multiple diagnostic modalities, serving healthcare providers and life sciences researchers. Headquartered in Switzerland, the company maintains operations in France, the United States, and Brazil.